TY - JOUR
T1 - Medical and psychosocial symptom clusters and their temporal patterns in people with cancer
AU - Gross, Samantha
AU - Koczwara, Bogda
AU - Beatty, Lisa
PY - 2025/12
Y1 - 2025/12
N2 - Purpose: Symptom clusters (SC) negatively impact functioning and quality of life (QOL). Existing SC research is largely cross-sectional, focused on advanced and/or single cancer types, and does not encompass physical, functional, and psychosocial symptoms. This secondary analysis examined SCs in newly diagnosed, actively treated patients across diverse cancers, assessed SC temporal stability, and identified core symptoms. Methods: Archival data from three RCTs of the Finding My Way intervention were analysed [1–3]. Physical, functional, and QOL symptoms were measured using the EORTC QLQ-C30 [4], and psychological symptoms were assessed via the DASS-21 [5]. SCs were identified through EFA at baseline (N = 300) and 3 months post-intervention in both control (n = 151) and intervention (n = 149) groups. Results: Physical (α =.85), psychological (α =.90), and gastrointestinal (α =.63) clusters were identified at baseline. Core symptoms were role functioning (.92), stress (−.92), and nausea and vomiting (.66), respectively. Only the psychological cluster was temporally stable. The gastrointestinal cluster appeared only at baseline, while the physical cluster was persistent but temporally unstable. Cluster presence was varied at baseline (physical = 83%, psychological = 42%, gastrointestinal = 29%) and at 3 months (control: psychological = 48%, physical = 46%, simultaneously = 42%; intervention: psychological = 41%, physical = 46%, simultaneously = 33%). Conclusion: Psychological, physical, and gastrointestinal clusters were identified, with only psychological demonstrating temporal stability. Stress and role functioning emerged as core symptoms. Future research should prioritise multicomponent interventions targeting psychological and physical SCs and core symptoms.
AB - Purpose: Symptom clusters (SC) negatively impact functioning and quality of life (QOL). Existing SC research is largely cross-sectional, focused on advanced and/or single cancer types, and does not encompass physical, functional, and psychosocial symptoms. This secondary analysis examined SCs in newly diagnosed, actively treated patients across diverse cancers, assessed SC temporal stability, and identified core symptoms. Methods: Archival data from three RCTs of the Finding My Way intervention were analysed [1–3]. Physical, functional, and QOL symptoms were measured using the EORTC QLQ-C30 [4], and psychological symptoms were assessed via the DASS-21 [5]. SCs were identified through EFA at baseline (N = 300) and 3 months post-intervention in both control (n = 151) and intervention (n = 149) groups. Results: Physical (α =.85), psychological (α =.90), and gastrointestinal (α =.63) clusters were identified at baseline. Core symptoms were role functioning (.92), stress (−.92), and nausea and vomiting (.66), respectively. Only the psychological cluster was temporally stable. The gastrointestinal cluster appeared only at baseline, while the physical cluster was persistent but temporally unstable. Cluster presence was varied at baseline (physical = 83%, psychological = 42%, gastrointestinal = 29%) and at 3 months (control: psychological = 48%, physical = 46%, simultaneously = 42%; intervention: psychological = 41%, physical = 46%, simultaneously = 33%). Conclusion: Psychological, physical, and gastrointestinal clusters were identified, with only psychological demonstrating temporal stability. Stress and role functioning emerged as core symptoms. Future research should prioritise multicomponent interventions targeting psychological and physical SCs and core symptoms.
KW - Core symptoms
KW - Functioning
KW - Online intervention
KW - QOL
KW - Symptom cluster
KW - Temporal stability
UR - http://www.scopus.com/inward/record.url?scp=105022219845&partnerID=8YFLogxK
U2 - 10.1007/s00520-025-10028-4
DO - 10.1007/s00520-025-10028-4
M3 - Article
C2 - 41258249
AN - SCOPUS:105022219845
SN - 0941-4355
VL - 33
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 12
M1 - 1085
ER -